Sugi Predict

Sugi Predict / Compounds / SCHEMBL29966992

SCHEMBL29966992

SCHEMBL29966992

N#Cc1ccc(CC(=O)NC2(C(=O)O)CCCCC2)cc1C1CC1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 6/20 0.40
▸ CTSS P25774 4/20 0.40
▸ CNR2 P34972 5/20 0.39
▸ CNR1 P21554 4/20 0.39
▸ ALDH1A1 P00352 1/20 0.37
▸ ADRB2 P07550 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ CTSK P43235 1/20 0.36
▸ CTSL P07711 6/20 0.35
▸ SHMT1 P34896 2/20 0.35
▸ SHMT2 P34897 2/20 0.35
▸ DRD4 P21917 1/20 0.35
▸ GPR132 Q9UNW8 1/20 0.34
▸ PTGDR2 Q9Y5Y4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23242486 1.00 CTSB (0.40) CTSBCTSSCNR2CNR1ALDH1A1
SCHEMBL23265267 0.99 CTSB (0.39) CTSBCTSSCNR2CNR1ALDH1A1
SCHEMBL23265385 0.97 SHMT1 (0.38) CTSBCTSSCNR2CNR1ALDH1A1
SCHEMBL23265264 0.94 DRD4 (0.36) CTSBCTSSCNR2CNR1ALDH1A1
SCHEMBL23265268 0.89 RXRA (0.34) CTSBCTSSCNR2CNR1CTSL
SCHEMBL23242489 0.88 MAPT (0.39) CTSBCTSSALDH1A1ADRB2HTT
SCHEMBL23242481 0.86 CTSB (0.37) CTSBCTSSCNR2CNR1ALDH1A1
SCHEMBL23265278 0.86 SCN9A (0.40) CTSBCTSSCTSKCTSL
SCHEMBL29045057 0.83 PTGDR2 (0.38) CTSBCTSSCNR2CNR1ALDH1A1
SCHEMBL23265262 0.81 CTSB (0.42) CTSBCTSSCNR2CNR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4618745-A1 USE OF ISOTIANIL FOR CONTROLLING PLASMODIOPHORA BRASSICA Bayer Aktiengesellschaft (DE) 2025-09-24 — — EP disclosed
US-20250280829-A1 USE OF (5S)-3-[3-(3-CHLORO-2-FLUOROPHENOXY)-6-METHYLPYRIDAZIN-4-YL]-5-(2-CHLORO-4-METHYLBENZYL)-5,6-DIHYDRO-4H-1,2,4-OXADIAZINE FOR CONTROLLING UNWANTED MICROORGANISMS BAYER AKTIENGESELLSCHAFT (DE) 2025-09-11 — — US disclosed
CN-120035584-A Substituted N-phenyluracils and salts thereof and their use as herbicidal agents 拜耳公司 2025-05-23 — — CN disclosed
WO-2025103929-A1 SUBSTITUTED N-BENZOIC ACID URACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2025-05-22 — — WO disclosed
CN-119522219-A Crystalline forms of (5S) -3- [3- (3-chloro-2-fluorophenoxy) -6-methylpyridazin-4-yl ] -5- (2-chloro-4-methylbenzyl) -5, 6-dihydro-4H-1, 2, 4-oxadiazine 拜耳公司 2025-02-25 — — CN disclosed
CN-119110684-A Use of (5S) -3- [3- (3-chloro-2-fluorophenoxy) -6-methylpyridazin-4-yl ] -5- (2-chloro-4-methylbenzyl) -5, 6-dihydro-4H-1, 2, 4-oxadiazine for controlling unwanted microorganisms 拜耳公司 2024-12-10 — — CN disclosed
CN-118632626-A (1, 4, 5-Trisubstituted-1H-pyrazol-3-yl) oxy-2-alkoxythioalkyl acids and derivatives thereof, salts thereof and use thereof as herbicidal agents 拜耳公司 2024-09-10 — — CN disclosed
WO-2024178190-A2 METHODS AND COMPOSITIONS FOR PPO HERBICIDE TOLERANCE MONSANTO TECHNOLOGY LLC (US) 2024-08-29 — — WO disclosed
WO-2024167793-A1 METHODS AND COMPOSITIONS FOR PPO HERBICIDE TOLERANCE MONSANTO TECHNOLOGY LLC (US) 2024-08-15 — — WO disclosed
EP-4384016-A1 ACTIVE COMPOUND COMBINATIONS AND FUNGICIDE COMPOSITIONS COMPRISING THOSE Bayer Aktiengesellschaft (DE) 2024-06-19 — — EP disclosed
WO-2024068517-A1 3-(HETERO)ARYL-5-CHLORODIFLUOROMETHYL-1,2,4-OXADIAZOLE AS FUNGICIDE BAYER AKTIENGESELLSCHAFT (DE) 2024-04-04 — — WO disclosed
WO-2024068519-A1 3-(HETERO)ARYL-5-CHLORODIFLUOROMETHYL-1,2,4-OXADIAZOLE AS FUNGICIDE BAYER AKTIENGESELLSCHAFT (DE) 2024-04-04 — — WO disclosed
CN-117616017-A N- (1, 3, 4-oxadiazol-2-yl) benzamide herbicides 拜耳公司 2024-02-27 — — CN disclosed
WO-2024015949-A2 METHODS AND COMPOSITIONS FOR PPO HERBICIDE TOLERANCE MONSANTO TECHNOLOGY LLC (US) 2024-01-18 — — WO disclosed
WO-2023092050-A1 BENEFICIAL COMBINATIONS WITH RECOMBINANT BACILLUS CELLS EXPRESSING A SERINE PROTEASE BAYER CROPSCIENCE LP (US) 2023-05-25 — — WO disclosed
WO-2023036707-A1 SUBSTITUTED 2,3-DIHYDRO[1,3]THIAZOLO[4,5-B]PYRIDINES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2023-03-16 — — WO disclosed
WO-2023017120-A1 ACTIVE COMPOUND COMBINATIONS AND FUNGICIDE COMPOSITIONS COMPRISING THOSE BAYER AKTIENGESELLSCHAFT (DE) 2023-02-16 — — WO disclosed
WO-2022253700-A1 SPECIFICALLY SUBSTITUTED PYRROLINE-2-ONES AND THEIR USE AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 2022-12-08 — — WO disclosed
WO-2022207494-A1 3-(HETERO)ARYL-5-CHLORODIFLUOROMETHYL-1,2,4-OXADIAZOLE AS FUNGICIDE BAYER AKTIENGESELLSCHAFT (DE) 2022-10-06 — — WO disclosed
WO-2022207496-A1 3-(HETERO)ARYL-5-CHLORODIFLUOROMETHYL-1,2,4-OXADIAZOLE AS FUNGICIDE BAYER AKTIENGESELLSCHAFT (DE) 2022-10-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250280829-A1 USE OF (5S)-3-[3-(3-CHLORO-2-FLUOROPHENOXY)-6-METHYLPYRIDAZIN-4-YL]-5-(2-CHLORO-4-METHYLBENZYL)-5,6-DIHYDRO-4H-1,2,4-OXADIAZINE FOR CONTROLLING UNWANTED MICROORGANISMS CYP4Z1, IL5, NT5C CTSB 2835/4885CTSS 3220/4885CNR2 1127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.